FAVA, Carmen

FAVA, Carmen  

SCIENZE CLINICHE E BIOLOGICHE  

Mostra records
Risultati 1 - 20 di 191 (tempo di esecuzione: 0.032 secondi).
Titolo Data di pubblicazione Autore(i) File
A retrospective real-life analysis of chronic myeloid leukemia patients in suboptimal response to imatinib: three centres experience. 2012 Ferrero D; Crisà E; Rege-Cambrin G; Fava C; Cerrano M; Pirillo F; Nicolosi M; Boccadoro M; Saglio G; Vitolo U; Pregno P.
Acute myeloid leukemia induced by mitoxantrone treatment for aggressive multiple sclerosis 2008 Capobianco M; Malucchi S; Ulisciani S; Fava C; Cambrin GR; Avonto L; Saglio G; Bertolotto A
Advances in the biology and therapy of patients with chronic myeloid leukaemia. 2009 Jabbour E; Fava C; Kantarjian H
Advances in the treatment of chronic myeloid leukemia 2013 Saglio G.; Fava C.
Alignment of Qx100/Qx200 Droplet Digital (Bio-Rad) and QuantStudio 3D (Thermofisher) Digital PCR for Quantification of BCR-ABL1 in Ph+ Chronic Myeloid Leukemia 2021 Carmen Fava, Simona Bernardi, Enrico Marco Gottardi, Roberta Lorenzatti, Laura Galeotti, Francesco Ceccherini, Francesco Cordoni, Filomena Daraio, Emilia Giugliano, Aleksandar Jovanovski, Jessica Petiti, Marta Varotto, Davide Barberio, Giovanna Rege-Cambrin, Paola Berchialla, Veronica Sciannameo, Michele Malagola, Giuseppe Saglio, Domenico Russo
Arterial Thrombotic Events in CML Patients Treated with First-Line Nilotinib: Incidence, Management and Impact on the Long Term Outcome - a Gimema CML WP Analysis 2017 Gugliotta, G; Castagnetti, F; Breccia, M; D'adda, M; Stagno, F; Levato, L; Carella, AM; Martino, B; Tiribelli, M; Fava, C; Gozzini, A; Salvucci, M; Cedrone, M; Trabacchi, E; Usala, E; Scortechini, AR; Luciano, L; Soverini, S; Cavo, M; Martinelli, G; Pane, F; Saglio, G; Baccarani, M; Rosti, G
Association of the hOCT1/ABCB1 genotype with efficacy and tolerability of imatinib in patients affected by chronic myeloid leukemia 2017 Galeotti, Laura; Ceccherini, Francesco; Domingo, Dario; Laurino, Marco; Polillo, Marialuisa; Di Paolo, Antonello; Baratè, Claudia; Fava, Carmen; D'Avolio, Antonio; Cervetti, Giulia; Guerrini, Francesca; Fontanelli, Giulia; Ciabatti, Elena; Grassi, Susanna; Arrigoni, Elena; Danesi, Romano; Petrini, Mario; Cornolti, Fulvio; Saglio, Giuseppe; Galimberti, Sara
Bcl-xL represents a therapeutic target in Philadelphia negative myeloproliferative neoplasms 2020 Petiti J.; Lo Iacono M.; Rosso V.; Andreani G.; Jovanovski A.; Podesta M.; Lame D.; Gobbi M.D.; Fava C.; Saglio G.; Frassoni F.; Cilloni D.
BCR-ABL inactivates cytosolic PTEN through casein kinase II mediated tail phosphorylation 2015 Morotti, Alessandro; Panuzzo, Cristina; Crivellaro, Sabrina; Carrà, Giovanna; Fava, Carmen; Guerrasio, Angelo; Pandolfi, Pier Paolo; Saglio, Giuseppe
The BCR-ABL Transcript Levels At 3 and 6 Months Predict the Long-Term Outcome of Chronic Myeloid Leukemia Patients Treated Frontline with Imatinib Mesylate: A Gimema CML WP Analysis. 2012 Fausto Castagnetti; Gabriele Gugliotta; Massimo Breccia; Giorgina Specchia; Elisabetta Abruzzese; Luciano Levato; Francesco Cavazzini; Alessandra Iurlo; Fabio Stagno; Dario Ferrero; Ferdinando Porretto; Bruno Martino; Serena Rupoli; Tamara Intermesoli; Carmen Fava; Francesca Palandri; Claudia Venturi; Simona Soverini; Nicoletta Testoni; Giuliana Alimena; Fabrizio Pane; Giuseppe Saglio; Giovanni Martinelli; Michele Baccarani; and Gianantonio Rosti.
BCR-ABL1 mutation not equal ponatinib resistance 2016 Saglio, Giuseppe; Fava, Carmen
The BCR-ABL1 Transcript Type Does Not Influence the Response and the Outcome of Chronic Myeloid Leukemia Patients Treated Frontline with Nilotinib. 2012 Fausto Castagnetti; Gabriele Gugliotta; Francesca Palandri; Massimo Breccia; Fabio Stagno; Luciano Levato; Carmen Fava; Luigiana Luciano; Tamara Intermesoli; Michele Cedrone; Angelo Michele Carella; Francesco Cavazzini; Diamante Turri; Paolo Avanzini; Ivana Pierri; Monia Lunghi; Claudia Venturi; Simona Soverini; Nicoletta Testoni; Giuliana Alimena; Giuseppe Saglio; Giovanni Martinelli; Fabrizio Pane; Michele Baccarani; and Gianantonio Rosti.
The BCR-ABL1 transcript type influences response and outcome in Philadelphia chromosome-positive chronic myeloid leukemia patients treated frontline with imatinib 2017 Castagnetti, Fausto; Gugliotta, Gabriele; Breccia, Massimo; Iurlo, Alessandra; Levato, Luciano; Albano, Francesco; Vigneri, Paolo; Abruzzese, Elisabetta; Rossi, Giuseppe; Rupoli, Serena; Cavazzini, Francesco; Martino, Bruno; Orlandi, Ester; Pregno, Patrizia; Annunziata, Mario; Usala, Emilio; Tiribelli, Mario; Sica, Simona; Bonifacio, Massimiliano; Fava, Carmen; Gherlinzoni, Filippo; Bocchia, Monica; Soverini, Simona; Bochicchio, Maria Teresa; Cavo, Michele; Giovanni, Martinelli; Saglio, Giuseppe; Pane, Fabrizio; Baccarani, Michele; Rosti, Gianantonio
Beyond the comfort zone of deep molecular response: discontinuation in major molecular response chronic myeloid leukemia 2019 Dragani M.; Rege-Cambrin G.; Ferrero D.; Abruzzese E.; Pregno P.; Elena C.; Cedrone M.; Santoro M.; Andreani G.; Saglio G.; Fava C.
The Biology of CML Supports SecondGeneration TKIs as Frontline Treatment 2017 Fava, C; Saglio, G
CALR-positive myeloproliferative disorder in a patient with Ph-positive chronic myeloid leukemia in durable treatment-free remission: a case report 2017 Dogliotti, Irene; Fava, Carmen; Serra, Anna; Gottardi, Enrico; Daraio, Filomena; Carnuccio, Francesca; Giugliano, Emilia; Bocchia, Monica; Saglio, Giuseppe; Rege-Cambrin, Giovanna
Can we and should we improve on frontline imatinib therapy for chronic myeloid leukemia? 2010 Fava C.; Saglio G.
CARDIOVASCULAR EVENTS IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH NILOTINIB FIRST-LINE: AN ANALISYS OF THE GIMEMA CML WP 2015 Gugliotta, G; Castagnetti, F; Breccia, M; Stagno, F; Martino, B; Fava, C; Luciano, L; Gozzini, A; Carella, Am; Abruzzese, E; Levato, L; Usala, E; Rossi, G; Bocchia, M; Tiribelli, M; Cavazzini, F; Salvucci, M; Cedrone, M; Trabacchi, E; Binotto, G; Venturi, C; Soverini, S; Cavo, M; Specchia, G; Alimena, G; Pane, F; Martinelli, G; Saglio, G; Baccarani, M; Rosti, G
Characterization and monitoring by droplet digital PCR of a novel BCR-ABL1 fusion transcript in a patient with chronic myeloid leukemia 2020 Petiti J, Dragani M, Castelli A, Lo Iacono M, Fantino C, Badino C, Serra A, Giugliano E, Andreani G, Rosso V, Gottardi E, Rege-Cambrin G, Saglio G, Cilloni D, Fava C.
CHARLSON COMORBIDITIES INDEX (CCI) MAY PREDICT COMPLIANCE AND DEVELOPMENT OF PLEURAL EFFUSIONS IN ELDERLY CHRONIC MYELOID LEUKEMIA (CML) RESISTANT/INTOLERANT PATIENTS TREATED WITH DASATINIB 2010 Breccia M; Latagliata R; Stagno F; Luciano L; Gozzini A; Castagnetti F;Ulisciani S;Cavazzini F;Annunziata M;Sorà F;Russo Rossi A; Pregno P; Porrini R; Abruzzese E; Giai V; Musto P;Tiribelli M; Binotto G; Occhini U; Vallone R; Martino B; Capodanno I; Spina F;Pane F; Santini V; Rosti G; Fava C; Alimena G